Concepedia

Allison Marlow

AM

Statistics

Publications

5

Citations

1.3K

H-Index

5

Active since

2004

Affiliations

Array BioPharma (United States)(Current)

Allison Marlow is an author at Array BioPharma (United States) specializing in medicine, pharmacology, and molecular oncology.

Publications per year

2004–2013

5

Publications

5

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Tammie C. Yeh, Vivienne Marsh, Bryan A. Bernat et al. · Clinical Cancer Research · 2007 · 583 citations · Full text

, , +14

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Alex A. Adjei, Roger B. Cohen, Wilbur A. Franklin et al. · Journal of Clinical Oncology · 2008 · 573 citations · Full text

, , +17

Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species

Kevin W. Hunt, Adam W. Cook, Ryan J. Watts et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

, , +17

Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor

Patrice A. Lee, Eli Wallace, Allison Marlow et al. · Cancer Research · 2010 · 37 citations

, , +17

Preclinical development of ARRY-142886, a potent and selective MEK inhibitor

Eli Wallace, Tammie C. Yeh, Joe Lyssikatos et al. · Cancer Research · 2004 · 18 citations

, , +15

1–5 of 5